Serina Therapeutics (SER) Q2 2026 Earnings

May 14Confirmed
Q2 2025
Q3 2025
Q4 2025
Q2 2026
-0.66
-0.58
-0.5
-0.43

Details

Expected EPS
-0.44
Actual EPS
-0.58
Surprise EPS
-0.14
Surprise Percent
-31.82%

Description

⁨Serina Therapeutics⁩ (⁦SER⁩) has reported earnings of ⁦-0.58⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts